- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06707116
Health Literacy As a Mediator Between Gender, Illness Identity, and Self-Efficacy
The Mediating Role of Health Literacy in the Relationship Between Gender Differences, Illness Identity, and Self-Efficacy Patients with Cardiac Diseases: a Structural Equation Model
The goal of this observational study is to understand the role of health literacy in shaping the relationship between gender differences, illness identity, and self-efficacy in geriatric patients with cardiac diseases. The main question it aims to answer is:
Does health literacy mediate the relationship between gender, illness identity, and self-efficacy in elderly cardiac patients?
Participants with diagnosed cardiac conditions, will complete online surveys assessing their health literacy, illness identity, and self-efficacy over a one-year period. Structural Equation Modeling (SEM) will be used to analyze the relationships among these variables.
Study Overview
Status
Conditions
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Mohammed ElSayed Zaky Principle Investigator, Ph.D
- Phone Number: 01000553254
- Email: Mohammed.Zaky@cu.edu.eg
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
The study population consists of patients aged 30 years and older who have been diagnosed with cardiac diseases, such as coronary artery disease, heart failure, or arrhythmias. These individuals are actively receiving regular medical care for their cardiac conditions and are living in the community or non-acute care settings.
The population includes both male and female participants to explore gender differences in illness identity, health literacy, and self-efficacy. Participants are expected to have a baseline level of health literacy sufficient to comprehend and complete the study surveys, as the research focuses on the mediating role of health literacy.
Description
Inclusion Criteria:
- Adults aged 30 years or older.
- Diagnosed with a cardiac disease (e.g., heart failure, coronary artery disease, arrhythmia).
- Able to provide informed consent.
- Sufficient health literacy to complete surveys in the study language.
- Currently under regular medical care for their cardiac condition.
Exclusion Criteria:
- Individuals with a cognitive impairment or diagnosis of dementia that could interfere with survey participation.
- Patients with co-morbid terminal illnesses that significantly impact life expectancy (e.g., advanced cancer).
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Study group
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Illness Identity Questionnaire (IIQ)
Time Frame: 1 month
|
Description: The Illness Identity Questionnaire (IIQ) is a 25-item, self-report, paper-and-pencil questionnaire that was initially used and validated in adolescents and young adults with type 1 diabetes mellitus.
Patients are asked to indicate how much they agree with 25 statements, using a 5-point Likert scale ranging from 1-5 (strongly disagree to strongly agree).
The IIQ consists of a 5-item rejection scale (items 1-5); 5-item acceptance scale (items 6-10); an 8-item engulfment scale (items 11-18); and 7-item enrichment scale (items 19-25).
|
1 month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cardiac Self-Efficacy Scale
Time Frame: 1 month
|
The Cardiac Self-Efficacy Scale (CSES) is a valuable tool used to assess how confident individuals with heart conditions feel about managing their illness and maintaining daily activities.
This scale provides insight into two main areas of self-efficacy: the ability to control symptoms, such as chest pain or fatigue, and the capacity to maintain physical and emotional well-being despite the challenges posed by their condition.
|
1 month
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Health Literacy
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.